PROstaTe Cancer - Exercise-STudy (PRO-TEST)
NCT02954783 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2019-12-18
Summary
Background and purpose: The purpose of this study is to investigate the effect of exercise on intratumoral natural killer (NK)-cell variability in patients with localized prostate cancer undergoing radical prostatectomy.
The primary hypothesis is that exercise induces epinephrine-mediated intratumoral natural killer (NK)-cell infiltration in patients with localized prostate cancer, and that the infiltration is greater in patients performing High Intensity Interval Training compared to usual care controls.
Currently there is a lack of randomized controlled trials examining different types of exercise in patients with localized prostate cancer. Moreover there is a need for studies including biological measurements to allow a full assessment of the effect of exercise on diverse biomarkers and mechanistic pathways, which may influence cancer survival.
Subjects: Patients with histologically verified prostate adenocarcinoma scheduled for radical prostatectomy at Urologic Department, Rigshospitalet, Copenhagen, Denmark.
Methods: In this randomized controlled pilot study 30 patients with localized prostate cancer undergoing radical prostatectomy will be included and randomized 2:1 to either High Intensity Interval Training (HIIT) exercise intervention or observational control receiving usual care from inclusion and until planned surgery (radical prostatectomy).
All patients will undergo assessments at inclusion (baseline) and at follow-up after the exercise intervention period (maximum 8 weeks) 3-5 days prior to surgery.
Assessments include: anthropometrics; blood pressure; resting hearth rate; cardiorespiratory fitness by cardiopulmonary exercise test (VO2 peak.); body composition by DXA scan; quality of life by self-report questionnaires; fasting blood sample measuring cholesterol, triglycerides, insulin, c-peptide, HbA1c, glucose, hormones and inflammatory markers.
Biological tissue from tumor (primary prostate biopsies) will be retrieved from the respective local pathological departments and from the perioperative prostate specimen and sent to protocol analyses.
Conditions
Interventions
- BEHAVIORAL
-
High Intensity Interval Training
Supervised aerobic High Intensity Interval Training program consisting of 4 weekly sessions of approximately 35 minutes. Patients will perform a test of maximum cardio-respiratory (VO2 peak test). Using the patient's individual wattmax, a personalized exercise program will be prescribed. After a light warm-up, patients will perform 25 min of aerobic high intensity interval training on a stationary bicycle, intervals will consist of cycles of HI intervals with 120% of wattmax for 1 min followed by recovery for 3 min at 30% of wattmax. Each session will be supervised by trained instructors to ensure proper technique, and progression in training load.
- BEHAVIORAL
-
Usual Care Observational Control
The reference group will receive the standard patient care program as provided by the Department of Urology, Rigshospitalet.This includes information regarding smoking cessation and alcohol reduction and a physiotherapist consultation regarding pelvic floor exercises. This group is allowed to exercise on their own initiative or participate in any standard care hospital- or municipality-based exercise program. This will be monitored by self-report.
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer
NCT02179762 ·Status: WITHDRAWN ·Phase: NA
-
EXTEND Exercise Trial
NCT02256111 ·Status: COMPLETED ·Phase: PHASE2
-
Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing
NCT02353715 ·Status: COMPLETED
-
Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients
NCT03526562 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate Cancer
NCT01300104 ·Status: COMPLETED ·Phase: NA
-
Resistance Training and Protein Supplementation for Prostate Cancer Survivors
NCT01909440 ·Status: COMPLETED ·Phase: NA
-
Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide
NCT02130947 ·Status: WITHDRAWN ·Phase: NA
-
Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer
NCT03880422 ·Status: RECRUITING ·Phase: NA
-
Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial
NCT03658486 ·Status: COMPLETED ·Phase: NA
-
Walking Football as a Supportive Medicine for Patients With Prostate Cancer
NCT04062162 ·Status: UNKNOWN ·Phase: NA
-
INTERVAL - Intense Exercise Trial for Men With Metastatic Castrate-Resistant Prostate Cancer
NCT04507698 ·Status: UNKNOWN ·Phase: NA
-
Exercise in Prostate Cancer
NCT06165302 ·Status: RECRUITING ·Phase: NA
-
Surgery in Treating Patients With Prostate Cancer
NCT00002938 ·Status: COMPLETED ·Phase: PHASE2
-
Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy
NCT01711892 ·Status: COMPLETED ·Phase: NA
-
Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer
NCT03275181 ·Status: COMPLETED
-
Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)
NCT03999151 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
NCT00967954 ·Status: UNKNOWN ·Phase: NA
-
Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate Cancer
NCT00739791 ·Status: COMPLETED ·Phase: NA
-
Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer
NCT02409212 ·Status: COMPLETED ·Phase: PHASE2
-
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
NCT05327465 ·Status: RECRUITING ·Phase: NA
-
Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC)
NCT01140373 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer
NCT02933255 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
NCT00664196 ·Status: SUSPENDED ·Phase: PHASE1
-
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
NCT01929239 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Vaccine Therapy in Curative Resected Prostate Cancer Patients
NCT01197625 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2